Pippa Medcalf

Collaborative Group (United States)

Pippa Medcalf's research has significantly advanced the understanding of Parkinson's disease management. In a study on adjuvant treatment for patients uncontrolled by levodopa therapy, findings suggest that catechol-o-methyltransferase or monoamine oxidase B inhibitors may offer improved effectiveness compared to dopamine agonists. Additionally, introducing a homeless healthcare team in hospitals has been shown to enhance staff knowledge and attitudes towards serving this vulnerable population. Research on movement disorders after stroke and restless legs syndrome highlights the need for comprehensive care strategies. Furthermore, guidelines for assessing and managing nocturnal Parkinson's disease symptoms have been established.